vTv Therapeutics (VTVT) Long-Term Debt Issuances (2014 - 2025)

vTv Therapeutics (VTVT) reported Long-Term Debt Issuances of $328000.0 for Q4 2025, up 412.5% sequentially from $64000.0 in Q3 2025.

vTv Therapeutics (VTVT) Long-Term Debt Issuances (2014 - 2025) Analysis & Trends

vTv Therapeutics (VTVT) has 11 years of Long-Term Debt Issuances data on file, last reported at $328000.0 in Q4 2025.

  • For the quarter ending Q4 2025, Long-Term Debt Issuances changed N/A year-over-year to $328000.0; the trailing twelve-month figure through Dec 2025 stood at $392000.0 (up 105.24% YoY), and the FY2025 full-year result was $392000.0, up 105.24% from the prior year.
  • Long-Term Debt Issuances climbed to $328000.0 in Q4 2025, from $64000.0 in the prior quarter.
  • In the past five years, Long-Term Debt Issuances ranged from a high of $803000.0 in Q3 2021 to a low of -$172000.0 in Q4 2021.
  • A 5-year average of $220000.0 and a median of $221500.0 in 2022 frame the typical range for Long-Term Debt Issuances.
  • Across the five-year window, Long-Term Debt Issuances plunged 103.47% in 2021 and surged 275.0% in 2022, its largest moves.
  • Tracing VTVT's Long-Term Debt Issuances over 5 years: stood at -$172000.0 in 2021, then surged by 275.0% to $301000.0 in 2022, then retreated by 17.28% to $249000.0 in 2023, then slipped by 23.29% to $191000.0 in 2024, then surged by 71.73% to $328000.0 in 2025.
  • Business Quant data shows VTVT's Long-Term Debt Issuances at $328000.0 in Q4 2025, $64000.0 in Q3 2025, and $191000.0 in Q1 2024.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Long-Term Debt Issuances (Qtr)
1 Oculis Holding AG 66,621.14 Bn 66,620.85 Bn - -
2 Nanobiotix 1,915.18 Bn 1,915.11 Bn - -
3 Akari Therapeutics 1,014.18 Bn 1,014.18 Bn - -
4 BeOne Medicines 471.27 Bn 466.48 Bn 1.35 Bn -
5 Vertex Pharmaceuticals 121.81 Bn 114.57 Bn 2.59 Bn -
6 Regeneron Pharmaceuticals 69.58 Bn 60.82 Bn 3.31 Bn -
7 Belite Bio 62.72 Bn 62.72 Bn - -
8 Argenx Se 55.51 Bn 50.33 Bn 1.41 Bn -
9 Revolution Medicines 37.35 Bn 37.35 Bn - -
10 vTv Therapeutics 19.21 Mn 19.21 Mn - -

Historic Data

Download Data
DateValue
Dec 31, 2025 328,000.00
Dec 31, 2025 328,000.00
Sep 30, 2025 64,000.00
Sep 30, 2025 64,000.00
Mar 31, 2024 191,000.00
Mar 31, 2024 191,000.00
Dec 31, 2023 249,000.00
Dec 31, 2023 249,000.00
Sep 30, 2023 93,000.00
Sep 30, 2023 93,000.00
Mar 31, 2023 224,000.00
Mar 31, 2023 224,000.00
Dec 31, 2022 301,000.00
Dec 31, 2022 301,000.00
Sep 30, 2022 219,000.00
Sep 30, 2022 219,000.00
Mar 31, 2022 256,000.00
Mar 31, 2022 256,000.00
Dec 31, 2021 -172,000.00
Dec 31, 2021 -172,000.00